Your browser doesn't support javascript.
loading
Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.
Vega-García, Nerea; Perez-Jaume, Sara; Esperanza-Cebollada, Elena; Vicente-Garcés, Clara; Torrebadell, Montserrat; Jiménez-Velasco, Antonio; Ortega, Margarita; Llop, Marta; Abad, Lorea; Vagace, José Manuel; Minguela, Alfredo; Pratcorona, Marta; Sánchez-Garcia, Joaquín; García-Calderón, Clara B; Gómez-Casares, María Teresa; Martín-Clavero, Estela; Escudero, Adela; Riñón Martinez-Gallo, Marta; Muñoz, Luz; Velasco, María Rosario; García-Morin, Marina; Català, Albert; Pascual, Antonia; Velasco, Pablo; Fernández, José Mª; Lassaletta, Alvaro; Fuster, José Luis; Badell, Isabel; Molinos-Quintana, Águeda; Molinés, Antonio; Guerra-García, Pilar; Pérez-Martínez, Antonio; García-Abós, Miriam; Robles Ortiz, Reyes; Pisa, Sandra; Adán, Rosa; Díaz de Heredia, Cristina; Dapena, José Luis; Rives, Susana; Ramírez-Orellana, Manuel; Camós, Mireia.
Affiliation
  • Vega-García N; Haematology Laboratory, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.
  • Perez-Jaume S; Developmental Tumor Biology Group, Leukemia and Other Pediatric Hemopathies, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
  • Esperanza-Cebollada E; Developmental Tumour Biology Laboratory, Institut de Recerca Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
  • Vicente-Garcés C; Haematology Laboratory, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.
  • Torrebadell M; Developmental Tumor Biology Group, Leukemia and Other Pediatric Hemopathies, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
  • Jiménez-Velasco A; Haematology Laboratory, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.
  • Ortega M; Developmental Tumor Biology Group, Leukemia and Other Pediatric Hemopathies, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
  • Llop M; Haematology Laboratory, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.
  • Abad L; Developmental Tumor Biology Group, Leukemia and Other Pediatric Hemopathies, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
  • Vagace JM; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
  • Minguela A; Haematology and Hemotherapy Laboratory, Hospital Carlos Haya, Málaga, Spain.
  • Pratcorona M; Cytogenetics Unit, Hematology Department, Hospital Vall d'Hebron, Barcelona, Spain.
  • Sánchez-Garcia J; Molecular Biology Unit, Clinical Analysis Service, La Fe University and Polytechnic Hospital, Valencia, Spain.
  • García-Calderón CB; Centro de Investigación Biomédica en Red - Cáncer (CIBERONC CB16/12/00284), Madrid, Spain.
  • Gómez-Casares MT; Paediatric Hemato-Oncology Laboratory, Hospital Niño Jesús, Madrid, Spain.
  • Martín-Clavero E; Haematology Laboratory, Hospital Materno Infantil, Badajoz, Spain.
  • Escudero A; Immunology Service, Clinic University Hospital Virgen de la Arrixaca (HCUVA) and Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain.
  • Riñón Martinez-Gallo M; Haematology Laboratory, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Muñoz L; Hematology Department, Hospital Reina Sofía, IMIBIC, UCO, Córdoba, Spain.
  • Velasco MR; Instituto de Biomedicina de Sevilla (IBIS/Consejo Superior de Investigaciones Científicas (CSIC)/Centro de Investigación Biomédica en Red - Cáncer (CIBERONC)), Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Seville, Spain.
  • García-Morin M; Biology and Molecular Haematology and Hemotherapy Service, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canarias, Spain.
  • Català A; Haematology-Cytology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Pascual A; Translational Research in Pediatric Oncology Hematopoietic Transplantation and Cell Therapy, Institute of Medical and Molecular Genetics (INGEMM), Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Velasco P; Immunology Laboratory, Hospital de Cruces, Bilbao, Spain.
  • Fernández JM; Haematology Laboratory, Hospital Parc Taulí, Sabadell, Spain.
  • Lassaletta A; Haematology Department, Hospital Virgen de la Salud, Toledo, Spain.
  • Fuster JL; Paediatric Hematology Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Badell I; Developmental Tumor Biology Group, Leukemia and Other Pediatric Hemopathies, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
  • Molinos-Quintana Á; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
  • Molinés A; Paediatric Hematology and Oncology Departments, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.
  • Guerra-García P; Haematology Department, Hospital Carlos Haya, Málaga, Spain.
  • Pérez-Martínez A; Pediatric Hematology and Oncology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • García-Abós M; Haematology and Oncology Department, Hospital de La Fe, Valencia, Spain.
  • Robles Ortiz R; Haematology and Oncology Department, Hospital Niño Jesús, Madrid, Spain.
  • Pisa S; Paediatric Oncohematology Department, Clinic University Hospital Virgen de la Arrixaca (HCUVA) and Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain.
  • Adán R; Paediatric Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Díaz de Heredia C; Instituto de Biomedicina de Sevilla (IBIS/Consejo Superior de Investigaciones Científicas (CSIC)/Centro de Investigación Biomédica en Red - Cáncer (CIBERONC)), Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Seville, Spain.
  • Dapena JL; Unit of Hematology and Hemotherapy, H.U. Materno Infantil de Canarias, Canarias, Spain.
  • Rives S; Paediatric Hemato-Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Ramírez-Orellana M; Department of Pediatric Hemato-Oncology and Stem Cell Transplantation, La Paz University Hospital, Madrid, Spain.
  • Camós M; Translational Research in Pediatric Oncology Hematopoietic Transplantation and Cell Therapy, Institute of Medical and Molecular Genetics (INGEMM), Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
Front Pediatr ; 8: 614521, 2020.
Article in En | MEDLINE | ID: mdl-33614543
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Prognostic_studies / Risk_factors_studies Language: En Journal: Front Pediatr Year: 2020 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Prognostic_studies / Risk_factors_studies Language: En Journal: Front Pediatr Year: 2020 Type: Article Affiliation country: Spain